Prosus in talks to put $200 million into PharmEasy

Prosus Ventures, previously known as Naspers Ventures, is in the final stages of investing around $200 million in online pharmacy platform PharmEasy amid the wider consolidation in the space, a person directly aware of the matter said.

Once completed, PharmEasy is expected to be valued at upwards of $1 billion. An application for the investment approval has been filed with the Competition Commission of India (CCI).